New Zealand’s Gene Technology Bill Delayed as Coalition Scrutinizes Details

Prime Minister Christopher Luxon has clarified that the ongoing delay of the Gene Technology Bill is not due to his coalition partner, New Zealand First. Instead, Luxon emphasized the government’s commitment to carefully address the complexities of the legislation. Initially scheduled for a report from Parliament’s health committee on July 31, 2023, the deadline has been pushed back twice, now set for October 10, 2023.

The proposed legislation aims to relax New Zealand’s stringent gene technology regulations, which have been in place for over 30 years. If passed, it would enable gene technologies to be used outside laboratory settings, with a new regulatory framework established within the Environmental Protection Authority. Support for the bill was noted during its first reading when New Zealand First expressed its backing but also raised concerns about the boundaries of gene technology applications.

Luxon noted that New Zealand is lagging behind countries such as Australia, Canada, and the United Kingdom, which have already begun to adopt these technologies. He expressed the need for the country to advance into the 21st century regarding gene technology regulation.

Legislative Progress and Concerns

The introduction of the bill in December 2022 by former science minister Judith Collins was met with mixed reactions. Collins stated that the legislation would not open the floodgates for genetic technologies but would provide a structured pathway for regulatory assessment to ensure public and environmental safety.

During discussions, Mark Patterson, a member of New Zealand First, emphasized the importance of examining the select committee report thoroughly. He highlighted the necessity of balancing New Zealand’s competitive advantage in being GE-free while also considering the potential benefits of gene technologies. “We must understand the trade-offs we are making. This is very much a risk-reward,” he remarked.

The current political landscape complicates the bill’s progression. Opposition from the Labour Party, the Greens, and Te Pāti Māori means that all three coalition partners must be in agreement for the legislation to advance. Labour’s science spokesperson, Reuben Davidson, has voiced skepticism regarding the coalition’s ability to unite on the fundamental aspects of the bill, suggesting that there is significant disagreement behind closed doors.

Government’s Commitment to Gene Technology

Despite these challenges, Luxon remains confident in the government’s direction. He assured that the hold-up is intentional, aimed at ensuring the legislation is thorough and effective. “We’re just taking a bit more time through the select committee process to make sure we get that drafted in the right way,” he stated.

Davidson expressed surprise at the Prime Minister’s optimism, noting that the bill appears to have encountered significant obstacles. He argued that the current state of the bill raises concerns about its clarity and the implications for trade.

As the coalition continues to navigate these complexities, the future of New Zealand’s Gene Technology Bill remains uncertain, contingent on the results of the upcoming report and the coalition’s ability to find common ground. The discussions surrounding this legislation reflect broader debates on the balance between innovation and caution in the realm of genetic technologies.